Morning Snapshot
Market Pulse: Crypto got hammered as Bitcoin retreated near $80,000 after rejection at $82,500, and Ethereum saw a swift unwind of high-leverage longs. Tech woes joined the rout: Cloudflare’s modest growth outlook and 1,100 headcount cuts stung investor confidence.
Key Movers: argenx surged on FDA approval for VYVGART therapies, Innodata ripped higher on an 88% Q1 earnings beat and raised outlook, while Cloudflare’s AI-driven layoffs made headlines.
Macro & Politics: With no fresh policy updates, markets focused tightly on corporate catalysts and approval timelines.
What’s Next: Watch for follow-through on biotech approvals and AI sector reactions when broader earnings season kicks off.
Market Commentary
What everyone’s missing is the knock-on strain from those forced Ethereum liquidations bleeding into the broader risk-on trade. Ethereum Sees Sharp Decline In High-Leverage Long Positions — See What Happens Next (newsBTC) isn’t just a crypto story—it’s a canary for leveraged bets across markets, and Bitcoin holds near $80,000 after rejection at $82,500; ETF outflows trigger cautious sentiment (The Times of India) underscores that margin calls aren’t contained to digital assets.
You might think argenx’s FDA win and Anthropic’s capital hunt have nothing in common, but both hinge on Wall Street’s flawed timing assumptions. argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo… (GlobeNewswire) and Anthropic cozies up to Elon Musk, IBM makes its case to win in AI, and Cerebras has big IPO plans (SiliconANGLE News) reveal that whether it’s biotech launches or AI mergers, execution speed is the real alpha generator.
Here’s the play: dial back those levered crypto specs, don’t chase every pure-play AI ticker after Cloudflare forecasts slower growth, disappointing AI-focused investors (Crypto Briefing), and rotate into tangible catalysts like argenx and Innodata Inc.’s blowout Q1 (Ibtimes.com.au). Be ready to pounce when FDA wins or record earnings beats send volatility screaming.
📈 Breaking Financial News
VYVGART and VYVGART Hytrulo are the first and only approved treatments for all serotypes of adult patients living with gMG – anti-AChR-Ab positive,…
NEW YORK — Innodata Inc. (NASDAQ: INOD) shares skyrocketed more than 88% in morning trading Thursday after the AI data engineering company delivered blockbuster first-quarter 2026 results that far exceeded expectations, dramatically raised its full-year reven…
Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to ReSTART…
Bitcoin hovers near the $80,000 mark. Experts note cautious sentiment following outflows from US-listed spot Bitcoin ETFs. Major altcoins like XRP, BNB, and Solana saw gains. The global crypto market capitalization increased. Institutional demand continues to…
Cloudflare's slower growth and rising AI costs may signal broader challenges for tech firms balancing innovation with profitability.
The post Cloudflare forecasts slower growth, disappointing AI-focused investors appeared first on Crypto Briefing.
Bitcoin In Serious Danger of Disappearing From Exchanges…
This could be the biggest “supply shock” in financial history! Bitcoin on exchanges is being bought up faster than miners can mine it. The smart money like BlackRock, Goldman Sachs, and MicroStrategy are doubling, tripling, quadrupling down. And they're doing everything they can to buy up ONE altcoin before prices blast-off like a Space X rocket. Discover the ONE altcoin smart money is buying up before Bitcoin's supply shock.
🔍 Market Analysis & Insights
— With fertility rates at historic lows, Femasys advances access to early infertility care through FemaSeed® Complete, enabling OB/GYNs to treat patients within their own practices — — With fertility rates at historic lows, Femasys advances access to early…
Longeveron announced that a constructive Type C meeting with the U.S. FDA was held to discuss the ongoing development of laromestrocel in HLHS….
Ethereum is experiencing a notable shift in derivatives positioning as high-leverage long positions decline sharply across the market. The reduction suggests that many overly aggressive bullish trades have either been closed voluntarily or forced out through …
SnoreStop Throat Spray 2026: The 30-Year-Old Snoring Solution That's Still Outperforming Everything New SnoreStop Throat Spray 2026: The 30-Year-Old Snoring Solution That's Still Outperforming Everything New
Model Context Protocol server for Sentimatix – Indian Stock Market Sentiment Intelligence
White House Insider Buck Sexton: “Trump's Next Move Will Shock the World”
dramatically increase U.S. power… and trigger a massive American market boom the likes of which we haven't seen in 75 years. Get the details here now.
💰 Investment Opportunities
Cloudflare beat Wall Street’s revenue and earnings estimates on Wednesday, announced it would cut 1,100 employees because artificial intelligence agents now do their work, and watched its stock fall 24 per cent on Thursday. The sequence is becoming the templa…
Biocon is shifting its strategy to focus on capacity utilization, margin expansion, and improved returns after significant investments in global capabilities. The company reported a 13% revenue increase for FY26, though net profit saw a substantial decline. B…
Waters Corporation (NYSE:WAT) was one of the stocks on Jim Cramer’s radar as he highlighted AI winners to buy for 2026. Cramer explained why the stock…
Intel’s stock has tripled in twelve months. Its chief executive still has not told most of his employees what the plan is. Lip-Bu Tan, who became CEO in March 2025, has spent the first fourteen months of his tenure building relationships outside the company r…
Money, and desperation, sure can pave over a lot of ill will. This week’s example: Anthropic signed a mammoth deal with Elon Musk’s SpaceX to use all of the computing capacity of SpaceX’s Colossus data center full of AI chips. Yes, that Elon Musk, the one who…
The Cross-Chain Giant Set for 1,000%+ Gains As crypto markets surge post-tariffs
Its transaction volume is skyrocketing across all major blockchains while its price remains suppressed as retail has yet to discover it – creating a coiled spring ready to release. Breaking: Access our urgent research on this cross-chain opportunity for just $3!